European Neuropsychopharmacology

杂志介绍

European Neuropsychopharmacology杂志介绍

《European Neuropsychopharmacology》是一本以English为主的未开放获取国际优秀期刊，中文名称欧洲神经精神药理学，本刊主要出版、报道医学-CLINICAL NEUROLOGY领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为6.1，最新CiteScore 指数为10.3。

本刊近期中国学者发表的论文主要有：

• Effect of psychotropics on the risk of COVID-19 in middle-aged and older adults

  Author: Ma, Yue; Li, Shu; Yang, Hongxi; Zhang, Yuan; Li, Huiping; Xu, Fusheng; Hou, Yabing; Zhang, Xinyu; Wang, Yaogang

• Association between the loudness dependence of auditory evoked potential, serotonergic neurotransmission and treatment outcome in patients with depression

  Author: Ip, Cheng-Teng; Ganz, Melanie; Ozenne, Brice; Olbrich, Sebastian; Beliveau, Vincent; Dam, Vibeke H.; Kohler-Forsberg, Kristin; Jorgensen, Martin B.; Frokjaer, Vibe G.; Knudsen, Gitte M.

• Inflammatory disequilibrium and lateral ventricular enlargement in treatment-resistant schizophrenia

  Author: Chen, Wenjin; Gou, Mengzhuang; Wang, Leilei; Li, Na; Li, Wei; Tong, Jinghui; Zhou, Yanfang; Xie, Ting; Yu, Ting; Feng, Wei; Li, Yanli; Chen, Song; Tian, Baopeng; Tan, Shuping; Wang, Zhiren; Pan, Shujuan; Luo, Xingguang; Zhang, Ping; Huang, Junchao; Tian, Li; Li, Chiang -Shan R.; Tan, Yunlong

• Functional asymmetry of thalamocortical networks in subjects at ultra-high risk for psychosis and first-episode schizophrenia

  Author: Furong Zhu, Yi Liu, Feng Liu, Ru Yang, Huabing Li, Jindong Chen, David N. Kennedy, Jingping Zhao, Wenbin Guo

英文介绍

European Neuropsychopharmacology杂志英文介绍

European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.